Company profile
Quantum BioPharma Ltd.
NASDAQ: QNTM · Healthcare · Biotechnology
Canadian filerHQ Toronto, ONCIK 0001771885Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 42
v0.1 · 5/100 weight · pillars only
↑ balance-sheet leverage, market scale · ↓ Piotroski F, filing timeliness
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$23.6M
Employees
17
as of 2026-08-21
Market cap
$22.0M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$23.6M-$23.6M2022
Total assets$11.2M$11.2M2025
Liabilities$6.1M$6.1M2025
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Quantum BioPharma Ltd.’s financial profile?
Quantum BioPharma Ltd. earned -$23.6M in FY2022 net income.
Peers · Healthcare
Tevogen Bio Holdings Inc.——Actuate Therapeutics Inc——NurExone Biologic Inc.——Werewolf Therapeutics, Inc.——Cellectar Biosciences, Inc.——ProMIS Neurosciences, Inc.——Key facts
CEOZeeshan Saeed
SectorHealthcare
IndustryBiotechnology
HeadquartersToronto, ON
ExchangeNASDAQ: QNTM
Employees17
IPO date2018-06-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.